Opinion | Published:

Spinal cord repair strategies: why do they work?

Nature Reviews Neuroscience volume 7, pages 644653 (2006) | Download Citation

Subjects

Abstract

There are now numerous preclinical reports of various experimental treatments promoting some functional recovery after spinal cord injury. Surprisingly, perhaps, the mechanisms that underlie recovery have rarely been definitively established. Here, we critically evaluate the evidence that regeneration of damaged pathways or compensatory collateral sprouting can promote recovery. We also discuss several more speculative mechanisms that might putatively explain or confound some of the reported outcomes of experimental interventions.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319–370 (1996).

  2. 2.

    et al. MR-pathologic comparisons of wallerian degeneration in spinal cord injury. AJNR Am. J. Neuroradiol. 16, 125–133 (1995).

  3. 3.

    et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378, 498–501 (1995).

  4. 4.

    , & Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417, 547–551 (2002).

  5. 5.

    et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640 (2002).

  6. 6.

    , , & Axonal regeneration of Clarke's neurons beyond the spinal cord injury scar after treatment with chondroitinase ABC. Exp. Neurol. 182, 160–168 (2003).

  7. 7.

    et al. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur. J. Neurosci. 11, 3873–3883 (1999).

  8. 8.

    , , , & Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17, 5560–5572 (1997).

  9. 9.

    & Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp. Neurol. 140, 218–229 (1996).

  10. 10.

    & Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 23, 83–91 (1999).

  11. 11.

    et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 34, 895–903 (2002).

  12. 12.

    et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. 19, 4370–4387 (1999).

  13. 13.

    Transplantation of purified populations of Schwann cells into lesioned adult rat spinal cord. J. Neurol. 242, S36–S39 (1994).

  14. 14.

    , & Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2002 (1997).

  15. 15.

    , , & Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181, 115–129 (2003).

  16. 16.

    et al. Transplantation of genetically modified fibroblasts expressing BDNF in adult rats with a subtotal hemisection improves specific motor and sensory functions. Neurorehabil. Neural Repair 15, 141–150 (2001).

  17. 17.

    , & Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J. Neurosci. 18, 10514–10524 (1998).

  18. 18.

    The sensory and motor role of impulses travelling in the dorsal columns towards cerebral cortex. Brain 93, 505–524 (1970).

  19. 19.

    , & Residual function after subtotal spinal cord transection in adult cats. Neurology 8, 518–521 (1958).

  20. 20.

    Effects on movement of surgical incisions into the human spinal cord. Brain 117, 337–346 (1994).

  21. 21.

    , & Functional regeneration of sensory axons into the adult spinal cord. Nature 403, 312–316 (2000).

  22. 22.

    et al. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord. J. Neurosci. 25, 8066–8076 (2005).

  23. 23.

    et al. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 24, 10511–10520 (2004).

  24. 24.

    , , , & Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 25, 9624–9636 (2005).

  25. 25.

    et al. Retinoic acid receptor β2 promotes functional regeneration of sensory axons in the spinal cord. Nature Neurosci. 9, 243–250 (2006).

  26. 26.

    , & Locomotor recovery following subtotal spinal cord lesions in a rat model. Neurosci. Lett. 87, 189–194 (1988).

  27. 27.

    , Jr, & Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch. Phys. Med. Rehabil. 80, 587–599 (1999).

  28. 28.

    , , , & Recovery of ambulation in motor-incomplete tetraplegia. Arch. Phys. Med. Rehabil. 78, 1169–1172 (1997).

  29. 29.

    & Plasticity of motor systems after incomplete spinal cord injury. Nature Rev. Neurosci. 2, 263–273 (2001).

  30. 30.

    & Spinal shock — comparative aspects and clinical relevance. J. Vet. Intern. Med. 19, 788–793 (2005).

  31. 31.

    , , , & Motor recovery after serial spinal cord lesions of defined descending pathways in cats. Neurosci. Res. 5, 68–73 (1987).

  32. 32.

    & Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J. Neurosci. 19, 1885–1894 (1999).

  33. 33.

    , , & Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc. Natl Acad. Sci. USA 98, 3513–3518 (2001).

  34. 34.

    , , & Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury. Nature Med. 11, 1355–1360 (2005).

  35. 35.

    et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nature Neurosci. 7, 269–277 (2004).

  36. 36.

    et al. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nature Neurosci. 1, 124–131 (1998).

  37. 37.

    et al. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J. Neurosci. 18, 4744–4757 (1998).

  38. 38.

    , , , & Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. Proc. Natl Acad. Sci. USA 98, 6929–6934 (2001).

  39. 39.

    , , & Reorganization of descending motor tracts in the rat spinal cord. Eur. J. Neurosci. 16, 1761–1771 (2002).

  40. 40.

    & Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23, 4219–4227 (2003).

  41. 41.

    , , , & Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol. Cell. Neurosci. 29, 26–39 (2005).

  42. 42.

    , , & Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J. Neurosci. 24, 6209–6217 (2004).

  43. 43.

    et al. Recovery and brain reorganization after stroke in adult and aged rats. Ann. Neurol. 58, 950–953 (2005).

  44. 44.

    , , & Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15, 116–120 (2005).

  45. 45.

    & Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? J. Anat. 204, 33–48 (2004).

  46. 46.

    , , & Perineuronal nets: past and present. Trends Neurosci. 21, 510–515 (1998).

  47. 47.

    et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298, 1248–1251 (2002).

  48. 48.

    & Degradation of chondroitin sulfate proteoglycans induces sprouting of intact purkinje axons in the cerebellum of the adult rat. J. Neurosci. 25, 7150–7158 (2005).

  49. 49.

    , & Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. J. Neurosci. 23, 7034–7044 (2003).

  50. 50.

    et al. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J. Neurosci. 26, 4406–4414 (2006).

  51. 51.

    , , , & Chondroitinase ABC-mediated restitution of electrophysiological function after deafferentation. Soc. Neurosci. Abstr. 619.3 (2004).

  52. 52.

    et al. Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord. J. Neurosci. 20, 4435–4445 (2000).

  53. 53.

    , , , & Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention. Prog. Brain Res. 152, 245–263 (2006).

  54. 54.

    et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neurosci. 8, 346–353 (2005).

  55. 55.

    , , & A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 103, 249–257 (2003).

  56. 56.

    Clinical management of chronic pain in spinal cord injury. Clin. J. Pain 8, 102–110 (1992).

  57. 57.

    & Spasticity after spinal cord injury. Spinal Cord. 43, 577–586 (2005).

  58. 58.

    Autonomic dysfunction in spinal cord injury: clinical presentation of symptoms and signs. Prog. Brain Res. 152, 1–8 (2006).

  59. 59.

    & Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine 26, S146–S160 (2001).

  60. 60.

    Locomotion and its recovery after spinal injury. Curr. Opin. Neurobiol. 10, 708–716 (2000).

  61. 61.

    & Locomotor training after human spinal cord injury: a series of case studies. Phys. Ther. 80, 688–700 (2000).

  62. 62.

    & Restoring walking after spinal cord injury. Prog. Neurobiol. 73, 107–126 (2004).

  63. 63.

    , & Nerve growth factor induces P2X(3) expression in sensory neurons. J. Neurochem. 77, 864–875 (2001).

  64. 64.

    , & BDNF: a neuromodulator in nociceptive pathways? Brain Res. Brain Res. Rev. 40, 240–249 (2002).

  65. 65.

    & Textbook of Pain 5th edn (Elsevier, London, 2005).

  66. 66.

    Demyelination in spinal cord injury. J. Neurol. Sci. 91, 1–14 (1989).

  67. 67.

    , & Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192, 384–393 (2005).

  68. 68.

    et al. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 191, S3–S16 (2005).

  69. 69.

    , , & Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 18, 5354–5365 (1998).

  70. 70.

    et al. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. J. Neurotrauma 11, 433–446 (1994).

  71. 71.

    et al. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Paraplegia 31, 216–224 (1993).

  72. 72.

    et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694–4705 (2005).

  73. 73.

    et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J. Neurosci. 25, 6947–6957 (2005).

  74. 74.

    , , & Syringomyelia as a sequel to traumatic paraplegia. Paraplegia 19, 67–80 (1981).

  75. 75.

    , & Observations on the pathology of several types of human spinal cord injury, with emphasis on the astrocyte response to penetrating injuries. Adv. Neurol. 72, 305–315 (1997).

  76. 76.

    , , , & Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19, 8182–8198 (1999).

  77. 77.

    & Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6, 712–724 (1994).

  78. 78.

    et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395–5406 (1997).

  79. 79.

    , & Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11, 1223–1236 (2005).

  80. 80.

    et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158, 351–365 (1999).

  81. 81.

    , , , & Long-term effects of methylprednisolone following transection of adult rat spinal cord. Eur. J. Neurosci. 11, 2453–2464 (1999).

  82. 82.

    Methylprednisolone treatment of acute spinal cord injury: an introduction. J. Neurotrauma. 8, S43–S46 (1991).

  83. 83.

    & Chronic central pain after spinal cord injury. J. Neurotrauma 14, 517–537 (1997).

  84. 84.

    et al. Upregulation of sodium channel Nav1. 3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 23, 8881–8892 (2003).

  85. 85.

    et al. Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J. Neurochem. 95, 998–1014 (2005).

  86. 86.

    et al. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp. Neurol. 199, 397–407 (2006).

  87. 87.

    , & Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444–462 (2005).

  88. 88.

    & Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308–4317 (2006).

  89. 89.

    , & A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1–21 (1995).

  90. 90.

    & Compensatory locomotor adjustments of rats with cervical or thoracic spinal cord hemisections. J. Neurotrauma 19, 239–256 (2002).

  91. 91.

    , & Limits on recovery in the corticospinal tract of the rat: partial lesions impair skilled reaching and the topographic representation of the forelimb in motor cortex. Brain Res. Bull. 66, 203–211 (2005).

  92. 92.

    , & Chronic pain after clip-compression injury of the rat spinal cord. Exp. Neurol. 178, 33–48 (2002).

  93. 93.

    et al. An analysis of changes in sensory thresholds to mild tactile and cold stimuli after experimental spinal cord injury in the rat. Neurorehabil. Neural Repair 14, 287–300 (2000).

  94. 94.

    , , & Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury. J. Neurosci. 19, 7405–7414 (1999).

  95. 95.

    et al. Autonomic dysreflexia and primary afferent sprouting after clip-compression injury of the rat spinal cord. J. Neurotrauma 18, 1107–1119 (2001).

  96. 96.

    Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury. Prog. Brain Res. 152, 265–274 (2006).

  97. 97.

    et al. Modification of urinary bladder function after spinal cord injury. Adv. Neurol. 72, 347–364 (1997).

  98. 98.

    Problems of sexual function after spinal cord injury. Prog. Brain Res. 152, 387–399 (2006).

  99. 99.

    Disordered control of the urinary bladder after human spinal cord injury: what are the problems? Prog. Brain Res. 152, 51–57 (2006).

  100. 100.

    , & Central nervous system regeneration: oligodendrocytes and myelin as non-permissive substrates for neurite growth. Prog. Brain Res. 78, 363–370 (1988).

  101. 101.

    et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 Nature 403, 434–439 (2000).

  102. 102.

    et al. Inhibitor of neurite outgrowth in humans. Nature 403, 383–384 (2000).

  103. 103.

    , , & Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439–444 (2000).

  104. 104.

    & Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 269–272 (1990).

  105. 105.

    No Nogo: now where to go? Neuron 38, 153–156 (2003).

  106. 106.

    Nogo and axon regeneration. Curr. Opin. Neurobiol. 14, 118–124 (2004).

  107. 107.

    & The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 26, 193–198 (2003).

  108. 108.

    , , , & A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13, 757–767 (1994).

  109. 109.

    et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417, 941–944 (2002).

  110. 110.

    , & The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 182, 399–411 (2003).

  111. 111.

    , & Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 71, 427–444 (2003).

  112. 112.

    & Regeneration beyond the glial scar. Nature Rev. Neurosci. 5, 146–156 (2004).

  113. 113.

    et al. An inhibitor of neurite outgrowth produced by astrocytes. J. Cell Sci. 107, 1687–1695 (1994).

  114. 114.

    & Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14, 7616–7628 (1994).

  115. 115.

    , , , & Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109, 111–130 (1990).

  116. 116.

    , , & Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19, 5810–5822 (1999).

  117. 117.

    , & Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136, 32–43 (1995).

  118. 118.

    , , & Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nature Neurosci. 4, 465–466 (2001).

  119. 119.

    , , , & Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J. Neurotrauma 22, 226–239 (2005).

  120. 120.

    et al. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell. Neurosci. 13, 143–166 (1999).

  121. 121.

    , , & Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J. Neurosci. 23, 7789–7800 (2003).

  122. 122.

    et al. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J. 18, 194–196 (2004).

  123. 123.

    et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur. J. Neurosci. 22, 3036–3046 (2005).

  124. 124.

    et al. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 25, 1169–1178 (2005).

  125. 125.

    , , & Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J. Neurotrauma 21, 932–943 (2004).

  126. 126.

    , , , & A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp. Neurol. 134, 261–272 (1995).

  127. 127.

    , , , & Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur. J. Neurosci. 10, 607–621 (1998).

  128. 128.

    & Transplantation and gene therapy: combined approaches for repair of spinal cord injury. Neuroscientist 7, 28–41 (2001).

  129. 129.

    , , & Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J. Physiol. 533, 83–89 (2001).

  130. 130.

    , , , & Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24, 6402–6409 (2004).

  131. 131.

    et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature Med. 10, 610–616 (2004).

  132. 132.

    Neuroanatomy: Text and Atlas 2nd edn (Appleton & Lange, Stamford, Connecticut, 1996).

Download references

Acknowledgements

The work of the authors is supported by grants from the Medical Research Council and the Wellcome Trust, whom we would like to thank. We would also like to thank T. Boucher and D. Bennett for advice on the manuscript.

Author information

Affiliations

  1. Elizabeth J. Bradbury is at the Neurorestoration Group, Wolfson Wing, Hodgkin Building, Guy's Campus, King's College London, London Bridge, London SE1 1UL, UK.

    • Elizabeth J. Bradbury
  2. Stephen B. McMahon is at the Neurorestoration Group and the London Pain Consortium, Wolfson Wing, Hodgkin Building, Guy's Campus, King's College London, London Bridge, London SE1 1UL, UK.

    • Stephen B. McMahon

Authors

  1. Search for Elizabeth J. Bradbury in:

  2. Search for Stephen B. McMahon in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Stephen B. McMahon.

Glossary

Allodynia

Pain from stimuli that are not normally painful.

Chondroitinase ABC

(ChABC). A bacterial enzyme that cleaves the sugar (glycosaminoglycan) chains from proteoglycan molecules, rendering them less inhibitory to growth.

Contact-placing responses

In response to light contact of the foot an animal will lift its limb and place it on a surface for support.

Glial scar

Following CNS injury, activated glial cells form a meshwork of interweaving processes that surround the lesion site. Scarring is important for sealing the wound but can also act as an impenetrable barrier to regeneration.

H-reflex

A monosynaptic reflex elicited by electrically stimulating a nerve with an electric stimulus.

Immediate-early genes

A family of genes that share the characteristic of having their expression rapidly and transiently induced on stimulation.

Preconditioning

A protective effect from injury achieved by a previous insult (thought to be mediated by pro-regenerative changes in the cell body triggered by the insult).

Pyramidotomy

Transection of the corticospinal tract (CST) at the level of the medullary pyramids in the brainstem. A unilateral pyramidotomy lesions the CST on one side, leaving the other side intact (thereby denervating one side of the spinal cord).

Rhizotomy

An injury to the spinal dorsal roots that results in an interruption of sensory input from the PNS into the spinal cord.

Transcranial magnetic stimulation

Involves creating a strong localized transient magnetic field that induces current flow in underlying neural tissue, causing a temporary change in activity in small regions of the brain.

Wallerian degeneration

Degeneration that occurs after axonal injury in the distal segment of a nerve fibre – the part no longer connected to the cell body.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrn1964

Further reading Further reading